Imperial College London

Professor Carlton A W Evans

Faculty of MedicineDepartment of Infectious Disease

Professor of Global Health
 
 
 
//

Contact

 

+44 (0)20 3313 3222carlton.evans Website

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Migliori:2021:10.5588/ijtld.21.0425,
author = {Migliori, GB and Marx, FM and Ambrosino, N and Zampogna, E and Schaaf, HS and van, der Zalm MM and Allwood, B and Byrne, AL and Mortimer, K and Wallis, RS and Fox, GJ and Leung, CC and Chakaya, JM and Seaworth, B and Rachow, A and Marais, BJ and Furin, J and Akkerman, OW and Yaquobi, FA and Amaral, A and Borisov, S and Caminero, JA and Carvalho, ACC and Chesov, D and Codecasa, LR and Teixeira, RC and Dalcolmo, MP and Datta, S and Dinh-Xuan, A-T and Duarte, R and Evans, CA and García-García, J-M and Günther, G and Hoddinott, G and Huddart, S and Ivanova, O and Laniado-Laborín, R and Manga, S and Manika, K and Mariandyshev, A and Mello, FCQ and Mpagama, SG and Muñoz-Torrico, M and Nahid, P and Ong, CWM and Palmero, DJ and Piubello, A and Pontali, E and Silva, DR and Singla, R and Spanevello, A and Tiberi, S and Udwadia, ZF and Vitacca, M and Centis, R and DAmbrosio, L and Sotgiu, G and Lange, C and Visca, D},
doi = {10.5588/ijtld.21.0425},
journal = {International Journal of Tuberculosis and Lung Disease},
pages = {797--813},
title = {Clinical standards for the assessment, management, and rehabilitation of post-TB lung disease},
url = {http://dx.doi.org/10.5588/ijtld.21.0425},
volume = {25},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BACKGROUND: Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR).METHODS: A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement).RESULTS: Five clinical standards were defined: Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR.CONCLUSION: This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD.
AU - Migliori,GB
AU - Marx,FM
AU - Ambrosino,N
AU - Zampogna,E
AU - Schaaf,HS
AU - van,der Zalm MM
AU - Allwood,B
AU - Byrne,AL
AU - Mortimer,K
AU - Wallis,RS
AU - Fox,GJ
AU - Leung,CC
AU - Chakaya,JM
AU - Seaworth,B
AU - Rachow,A
AU - Marais,BJ
AU - Furin,J
AU - Akkerman,OW
AU - Yaquobi,FA
AU - Amaral,A
AU - Borisov,S
AU - Caminero,JA
AU - Carvalho,ACC
AU - Chesov,D
AU - Codecasa,LR
AU - Teixeira,RC
AU - Dalcolmo,MP
AU - Datta,S
AU - Dinh-Xuan,A-T
AU - Duarte,R
AU - Evans,CA
AU - García-García,J-M
AU - Günther,G
AU - Hoddinott,G
AU - Huddart,S
AU - Ivanova,O
AU - Laniado-Laborín,R
AU - Manga,S
AU - Manika,K
AU - Mariandyshev,A
AU - Mello,FCQ
AU - Mpagama,SG
AU - Muñoz-Torrico,M
AU - Nahid,P
AU - Ong,CWM
AU - Palmero,DJ
AU - Piubello,A
AU - Pontali,E
AU - Silva,DR
AU - Singla,R
AU - Spanevello,A
AU - Tiberi,S
AU - Udwadia,ZF
AU - Vitacca,M
AU - Centis,R
AU - DAmbrosio,L
AU - Sotgiu,G
AU - Lange,C
AU - Visca,D
DO - 10.5588/ijtld.21.0425
EP - 813
PY - 2021///
SN - 1027-3719
SP - 797
TI - Clinical standards for the assessment, management, and rehabilitation of post-TB lung disease
T2 - International Journal of Tuberculosis and Lung Disease
UR - http://dx.doi.org/10.5588/ijtld.21.0425
UR - http://hdl.handle.net/10044/1/102996
VL - 25
ER -